As SmileDirectClub faces intense investor scrutiny following a report from short-seller Hidenburg Research which gave the stock a $2 dollar price target, claiming it was dangerous for customers, competitor Orthly says it isn’t at risk. Orthly co-founder, Toni Oloko, joined Cheddar to discuss.